Skip to main content
Top
Published in: Acta Diabetologica 5/2013

01-10-2013 | Original Article

Evidence of selection at insulin receptor substrate-1 gene loci

Author: Issei Yoshiuchi

Published in: Acta Diabetologica | Issue 5/2013

Login to get access

Abstract

Type 2 diabetes mellitus (T2DM) is a complex disease characterized by insulin resistance and defect of insulin secretion. The worldwide prevalence of T2DM is steadily increasing. T2DM is also significantly associated with obesity, coronary artery disease (CAD), and metabolic syndrome. There is a clear difference in the prevalence of T2DM among populations, and T2DM is highly heritable. Human adaptations to environmental changes in food supply, lifestyle, and geography may have pressured the selection of genes associated with the metabolism of glucose, lipids, carbohydrates, and energy. The insulin receptor substrate-1 (IRS1) gene is considered a major T2DM gene, and common genetic variations near the IRS1 gene were found to be associated with T2DM, insulin resistance, adiposity, and CAD. Here, we aimed to find evidence of selection at the IRS1 gene loci using the HapMap population data. We investigated a 3-step test procedure—Wright’s F statistics (Fst), the long-range haplotype (LRH) test, and the integrated haplotype score (iHS) test—to detect selection at the IRS1 gene loci using the HapMap population data. We observed that 1 CAD-associated SNP (rs2943634) and 1 adiposity- and insulin resistance-associated SNP (rs2943650) exhibited high Fst values. We also found selection at the IRS1 gene loci by the LRH test and the iHS test. These findings suggest evidence of selection at the IRS1 gene loci and that further studies should examine the adaptive evolution of T2DM genes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMedCrossRef Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMedCrossRef
2.
go back to reference Almgren P, Lehtovirta M, Isomaa B et al (2011) Heritability and familiarity of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia 54:2811–2819PubMedCrossRef Almgren P, Lehtovirta M, Isomaa B et al (2011) Heritability and familiarity of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia 54:2811–2819PubMedCrossRef
3.
go back to reference Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H (1999) Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance—a population-based twin study. Diabetologia 42:139–145PubMedCrossRef Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H (1999) Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance—a population-based twin study. Diabetologia 42:139–145PubMedCrossRef
4.
go back to reference Das SK, Elbein SC (2006) The genetic basis of type 2 diabetes. Cellscience 2:100–131PubMed Das SK, Elbein SC (2006) The genetic basis of type 2 diabetes. Cellscience 2:100–131PubMed
6.
go back to reference Diamond J (2002) Evolution, consequences and future of plant and animal domestication. Nature 418:700–707PubMedCrossRef Diamond J (2002) Evolution, consequences and future of plant and animal domestication. Nature 418:700–707PubMedCrossRef
7.
go back to reference Tishkoff SA, Varkonyi R, Cahinhinan N et al (2001) Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 293:455–462PubMedCrossRef Tishkoff SA, Varkonyi R, Cahinhinan N et al (2001) Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 293:455–462PubMedCrossRef
8.
go back to reference Sabeti PC, Reich DE, Higgins JM et al (2002) Detecting recent positive selection in the human genome from haplotype structure. Nature 419:832–837PubMedCrossRef Sabeti PC, Reich DE, Higgins JM et al (2002) Detecting recent positive selection in the human genome from haplotype structure. Nature 419:832–837PubMedCrossRef
9.
go back to reference Helgason A, Pálsson S, Thorleifsson G et al (2007) Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39:218–225PubMedCrossRef Helgason A, Pálsson S, Thorleifsson G et al (2007) Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39:218–225PubMedCrossRef
10.
go back to reference Rung J, Cauchi S, Albrechtsen A et al (2009) Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 41:1110–1115PubMedCrossRef Rung J, Cauchi S, Albrechtsen A et al (2009) Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 41:1110–1115PubMedCrossRef
11.
go back to reference Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:578–589CrossRef Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:578–589CrossRef
12.
go back to reference Kilpeläinen TO, Zillikens MC, Stančákova A et al (2011) Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 43:753–763PubMedCrossRef Kilpeläinen TO, Zillikens MC, Stančákova A et al (2011) Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 43:753–763PubMedCrossRef
13.
go back to reference Samani NJ, Erdmann J, Hall AS et al (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357:443–453PubMedCrossRef Samani NJ, Erdmann J, Hall AS et al (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357:443–453PubMedCrossRef
14.
go back to reference The International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299–1320CrossRef The International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299–1320CrossRef
15.
go back to reference Novembre J, Di Rienzo A (2009) Spatial patterns of variation due to natural selection in humans. Nat Rev Genet 10:745–755PubMedCrossRef Novembre J, Di Rienzo A (2009) Spatial patterns of variation due to natural selection in humans. Nat Rev Genet 10:745–755PubMedCrossRef
16.
go back to reference Holsinger KE, Weir BS (2009) Genetics in geographically structured populations: defining, estimating and interpreting F(ST). Nat Rev Genet 10:639–650PubMedCrossRef Holsinger KE, Weir BS (2009) Genetics in geographically structured populations: defining, estimating and interpreting F(ST). Nat Rev Genet 10:639–650PubMedCrossRef
17.
go back to reference Voight BF, Kudaravalli S, Wen X, Pritchard JK (2006) A map of recent positive selection in the human genome. PLoS Biol 4:446–458CrossRef Voight BF, Kudaravalli S, Wen X, Pritchard JK (2006) A map of recent positive selection in the human genome. PLoS Biol 4:446–458CrossRef
18.
go back to reference Excoffier L, Laval G, Schneider S (2005) Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1:47–50 Excoffier L, Laval G, Schneider S (2005) Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1:47–50
19.
go back to reference Southam L, Soranzo N, Montgomery SB et al (2009) Is the thrifty genotype hypothesis supported by evidence based on confirmed type 2 diabetes- and obesity-susceptibility variants? Diabetologia 52:1846–1851PubMedCrossRef Southam L, Soranzo N, Montgomery SB et al (2009) Is the thrifty genotype hypothesis supported by evidence based on confirmed type 2 diabetes- and obesity-susceptibility variants? Diabetologia 52:1846–1851PubMedCrossRef
20.
go back to reference Pickrell JK, Coop G, Novembre J et al (2009) Signals of recent positive selection in a worldwide sample of human populations. Genome Res 19:826–837PubMedCrossRef Pickrell JK, Coop G, Novembre J et al (2009) Signals of recent positive selection in a worldwide sample of human populations. Genome Res 19:826–837PubMedCrossRef
21.
go back to reference Mountain JL, Risch N (2004) Assessing genetic contributions to phenotypic differences among ‘racial’ and ‘ethnic’ groups. Nat Genet 36:S48–S53PubMedCrossRef Mountain JL, Risch N (2004) Assessing genetic contributions to phenotypic differences among ‘racial’ and ‘ethnic’ groups. Nat Genet 36:S48–S53PubMedCrossRef
22.
go back to reference Bersaglieri T, Sabeti PC, Patterson N et al (2004) Genetic signatures of strong recent positive selection at the lactase gene. Am J Hum Genet 74:1111–1120PubMedCrossRef Bersaglieri T, Sabeti PC, Patterson N et al (2004) Genetic signatures of strong recent positive selection at the lactase gene. Am J Hum Genet 74:1111–1120PubMedCrossRef
23.
go back to reference Wooding S, Kim UK, Bamshad MJ et al (2004) Natural selection and molecular evolution in PTC, a bitter-taste receptor gene. Am J Hum Genet 74:637–646PubMedCrossRef Wooding S, Kim UK, Bamshad MJ et al (2004) Natural selection and molecular evolution in PTC, a bitter-taste receptor gene. Am J Hum Genet 74:637–646PubMedCrossRef
24.
go back to reference Bamshad MJ, Mummidi S, Gonzalez E et al (2002) A strong signature of balancing selection in the 5’ cis-regulatory region of CCR5. Proc Natl Acad Sci USA 99:10539–10544PubMedCrossRef Bamshad MJ, Mummidi S, Gonzalez E et al (2002) A strong signature of balancing selection in the 5’ cis-regulatory region of CCR5. Proc Natl Acad Sci USA 99:10539–10544PubMedCrossRef
25.
go back to reference Darwin C (1859) The origin of species by means of natural selection. Murray, London Darwin C (1859) The origin of species by means of natural selection. Murray, London
26.
go back to reference Maskarinec G, Erber E, Grandinetti A et al (2009) Diabetes incidence based on linkages with health plans: the multiethnic cohort. Diabetes 58:1732–1738PubMedCrossRef Maskarinec G, Erber E, Grandinetti A et al (2009) Diabetes incidence based on linkages with health plans: the multiethnic cohort. Diabetes 58:1732–1738PubMedCrossRef
27.
go back to reference Rothenberg PL, Lane WS, Karasik A, Backer J, White M, Kahn CR (1991) Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase. J Biol Chem 266:8302–8311PubMed Rothenberg PL, Lane WS, Karasik A, Backer J, White M, Kahn CR (1991) Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase. J Biol Chem 266:8302–8311PubMed
28.
go back to reference Sun XJ, Rothenberg P, Kahn CR et al (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73–77PubMedCrossRef Sun XJ, Rothenberg P, Kahn CR et al (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73–77PubMedCrossRef
29.
go back to reference Folli F, Saad MJ, Backer JM, Kahn CR (1992) Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J Biol Chem 267:22171–22177PubMed Folli F, Saad MJ, Backer JM, Kahn CR (1992) Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J Biol Chem 267:22171–22177PubMed
30.
go back to reference Folli F, Saad MJ, Backer JM, Kahn CR (1993) Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest 92:1787–1794PubMedCrossRef Folli F, Saad MJ, Backer JM, Kahn CR (1993) Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest 92:1787–1794PubMedCrossRef
31.
go back to reference Folli F, Saad MJ, Kahn CR (1996) Insulin receptor/IRS-1/PI 3-kinase signaling system in corticosteroid-induced insulin resistance. Acta Diabetol 33:185–192PubMedCrossRef Folli F, Saad MJ, Kahn CR (1996) Insulin receptor/IRS-1/PI 3-kinase signaling system in corticosteroid-induced insulin resistance. Acta Diabetol 33:185–192PubMedCrossRef
32.
go back to reference Araki E, Lipes MA, Patti ME et al (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186–190PubMedCrossRef Araki E, Lipes MA, Patti ME et al (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186–190PubMedCrossRef
33.
go back to reference Tamemoto H, Kadowaki T, Tobe K et al (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182–186PubMedCrossRef Tamemoto H, Kadowaki T, Tobe K et al (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182–186PubMedCrossRef
34.
go back to reference Abe H, Yamada N, Kamata K et al (1998) Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 101:1784–1788PubMedCrossRef Abe H, Yamada N, Kamata K et al (1998) Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 101:1784–1788PubMedCrossRef
35.
go back to reference Neel JV (1962) Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet 14:353–362PubMed Neel JV (1962) Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet 14:353–362PubMed
Metadata
Title
Evidence of selection at insulin receptor substrate-1 gene loci
Author
Issei Yoshiuchi
Publication date
01-10-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 5/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-012-0414-1

Other articles of this Issue 5/2013

Acta Diabetologica 5/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.